MAPT and Alzheimer disease: Pan-neuronal expression of either the secreted human 42-amino-acid Aβ peptide or the tau protein (wild-type 2N4R isoform) recapitulates age-dependent neuronal loss and progressive CNS dysfunction, including locomotor impairment, and these experimental models have proven useful for prior functional dissection of AD candidate genes60,61.